CVE-2025-61940 | BDVDB-2026-303671 Detail
Mirion MedicalEC2 Software NMIS BioDose
Description#
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Impact#
Per CVSS v3.1: confidentiality impact high, integrity impact high, availability impact low. Attack vector: network.
Weaknesses#
References#
Exploit#
No public exploit known
History#
- Version 1Record published in the CVE List.
- Version 2Most recent update recorded in the CVE List.